Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

4

SEC Filing Details

Document Details

Form
Filing Date
Jun 22, 2018
Document Date
Jun 21, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC
Filer
ZUERBLIS KENNETH J


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved